Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase)in Patients With Pancreatic Cancer
Condition(s):Pancreatic CancerLast Updated:October 15, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Pancreatic CancerLast Updated:October 15, 2021Completed
Condition(s):Acute Lymphoblastic Leukemia; PancreatitisLast Updated:December 9, 2016Completed
Condition(s):Acute Lymphoblastic Leukemia; Lymphoblastic LymphomaLast Updated:November 3, 2023Active, not recruiting
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:February 6, 2024Completed
Condition(s):Acute Lymphoblastic Leukemia; Non Hodgkins LymphomaLast Updated:April 26, 2017Completed
Condition(s):Pancreatic Adenocarcinoma MetastaticLast Updated:July 27, 2018Completed
Condition(s):Leukemia, Lymphocytic, AcuteLast Updated:June 29, 2015Completed
Condition(s):B Acute Lymphoblastic Leukemia; B Lymphoblastic Lymphoma; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent B Lymphoblastic Lymphoma; Recurrent T Lymphoblastic Leukemia/Lymphoma; Refractory B Lymphoblastic Lymphoma; Refractory T Lymphoblastic Lymphoma; T Acute Lymphoblastic Leukemia; T Lymphoblastic LymphomaLast Updated:November 14, 2018Withdrawn
Condition(s):Extranodal NK-T-Cell LymphomaLast Updated:October 22, 2020Unknown status
Condition(s):Acute Lymphoblastic LeukaemiaLast Updated:November 13, 2013Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.